The American Psychiatric Association Foundation Set to Open Its Headquarter Location in Washington DC
OAKLAND, Calif., March 6, 2018 (Newswire.com) - Owen Garrick M.D., M.B.A. will be attending the grand opening of the American Psychiatric Association Foundation, APAF, headquarters on March 16, 2018.
The American Psychiatric Association Foundation is a nonprofit organization that complements the professionalism of the American Psychiatric Association (APAF) by focusing on, and playing leadership roles in, the nation’s most pressing social mental health issues across our society. Their mission is to raise awareness and overcome barriers, invest in the future leaders of psychiatry, support research and training to improve mental health care, and lead partnerships to address public challenges in mental health. (“American Psychiatric Association Foundation,” n.d.)
I believe the work that the American Psychiatric Association Foundation has done in breaking down the stigmas of mental health is highly commendable. I feel honored to be a part of this event and looking forward to the future accomplishments from APAF.
Dr. Owen Garrick, CEO Bridge Clinical Research
“I believe the work that American Psychiatric Association Foundation has done in breaking down the stigmas of mental health is highly commendable. I feel honored to be a part of this groundbreaking event and looking forward to the future accomplishments from APAF,” Dr. Owen Garrick, CEO Bridge Clinical Research.
Dr. Garrick is currently the Board of Director Secretary for APAF. He serves the American Psychiatric Associations philanthropic subsidiary working to create a mentally healthy nation by advancing mental health, overcoming mental illness, and eliminating stigma. He recommends and evaluates programs that promote awareness of mental health and the effectiveness of treatment, and the importance of early intervention and access to care. Dr. Garrick also advises on research that contributes to the scientific base of psychiatric practice and informs health policy.
Source: Bridge Clinical Research